+462.0%
MRNA vs STLD
+84.3%
+377.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | STLD | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -1.5% | +2.2% | -0.4% |
| 7D | -8.2% | -3.6% | -4.6% | -10.7% |
| 30D | +125.6% | -10.1% | +135.6% | +123.2% |
| 3M | +197.1% | -11.4% | +208.5% | +196.9% |
| 6M | +148.5% | +30.8% | +117.7% | +113.4% |
| YTD | +363.3% | +40.7% | +322.6% | +279.4% |
| 1Y | +462.0% | +80.8% | +381.2% | +276.3% |
| All | +462.0% | +84.3% | +377.7% | +276.3% |
Cumulative growth
Daily Returns
Daily percentage return beside STLD.
Daily Out/Under-Performance
Portfolio return minus STLD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × STLD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded STLD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling